TY  - RPRT
TI  - De novo drug designing coupled with brute force screening and structure guided lead optimization gives highly specific inhibitor of METTL3: a potential cure for Acute Myeloid Leukaemia
AU  - Ganguly, M.
AU  - Gupta, R.
AU  - Roychowdhury, A.
AU  - Hazra, D.
PY  - 2023
DO  - 10.1101/2023.09.11.556977
UR  - https://www.biorxiv.org/content/10.1101/2023.09.11.556977v1
ID  - 10.1101/2023.09.11.556977
ER  -